Insider · CIK 0001187716
Mary Lake Ph D Polan
Files at QDEL (QuidelOrtho Corp). First filing Nov 24, 2025, latest Nov 24, 2025.
In brief
Mary Lake Ph D Polan files SEC Form 4 as director at QDEL (QuidelOrtho Corp). Since Nov 24, 2025, Mary Lake Ph D Polan has reported 1 open-market buy worth $22k and 0 open-market sells worth $0, the latest filed on Nov 24, 2025.
A track record needs three past buys with six months of prices behind them; Mary Lake Ph D Polan has 0, so none is measured yet.
The newest scored trade: bought $22k of QDEL on Nov 21, 2025, filed Nov 24, 2025, scored 41 (moderate). In the last 12 months: 1 buy worth $22k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
QDEL: QuidelOrtho Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | QuidelOrtho Corp | $22k 1,000 shares | +9% | +23% from low-49% from high |
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +15,532 | $0.00 | $0 | 15,532 | Jun 29, 2026 |
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Converted)derivative | +5,547 | $0.00 | $0 | 5,547 | Jun 29, 2026 |
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Premium)derivative | +1,664 | $0.00 | $0 | 1,664 | Jun 29, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +749 | $0.00 | $0 | 20,218 | Jun 9, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +224 | $0.00 | $0 | 20,442 | Jun 9, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Converted)derivative | -749 | $0.00 | $0 | 0 | Jun 9, 2026 |
| Jun 6, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Premium)derivative | -224 | $0.00 | $0 | 0 | Jun 9, 2026 |
| May 29, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +6,829 | $0.00 | $0 | 19,469 | Jun 2, 2026 |
| May 29, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -6,829 | $0.00 | $0 | 0 | Jun 2, 2026 |
| Nov 21, 2025 | QDEL QuidelOrtho Corp | POpen-market purchase Common Stock | +1,000 | $22.43 | $22k | 12,640 | Nov 24, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +6,829 | $0.00 | $0 | 6,829 | Jun 2, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Converted)derivative | +2,439 | $0.00 | $0 | 2,439 | Jun 2, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Premium)derivative | +731 | $0.00 | $0 | 731 | Jun 2, 2025 |
| May 22, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +4,929 | $0.00 | $0 | 11,640 | May 27, 2025 |
| May 22, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -4,929 | $0.00 | $0 | 0 | May 27, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +427 | $0.00 | $0 | 6,583 | May 20, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +128 | $0.00 | $0 | 6,711 | May 20, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Converted)derivative | -427 | $0.00 | $0 | 0 | May 20, 2025 |
| May 18, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Premium )derivative | -128 | $0.00 | $0 | 0 | May 20, 2025 |
| May 24, 2024 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +2,416 | $0.00 | $0 | 6,156 | May 29, 2024 |
| May 24, 2024 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -2,416 | $0.00 | $0 | 0 | May 29, 2024 |
| Aug 28, 2020 | QDEL QuidelOrtho Corp | GGift Common Stock | -3,300 | $0.00 | $0 | 3,740 | May 23, 2024 |
| May 22, 2024 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +4,929 | $0.00 | $0 | 4,929 | May 23, 2024 |
| May 22, 2024 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Converted)derivative | +1,760 | $0.00 | $0 | 1,760 | May 23, 2024 |
| May 22, 2024 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Premium)derivative | +528 | $0.00 | $0 | 528 | May 23, 2024 |
| May 12, 2024 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +273 | $0.00 | $0 | 6,958 | May 14, 2024 |
| May 12, 2024 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +82 | $0.00 | $0 | 7,040 | May 14, 2024 |
| May 12, 2024 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Converted)derivative | -273 | $0.00 | $0 | 0 | May 14, 2024 |
| May 12, 2024 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Premium)derivative | -82 | $0.00 | $0 | 0 | May 14, 2024 |
Questions about Mary Lake Ph D Polan
Answered from the filings on this page, as of the latest one.
Is Mary Lake Ph D Polan buying or selling?
In the last 12 months Mary Lake Ph D Polan reported 1 open-market buy worth $22k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $22k of QDEL on Nov 21, 2025. Grants, option exercises and tax withholding are not counted.
How did Mary Lake Ph D Polan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mary Lake Ph D Polan has 0.
Where does Mary Lake Ph D Polan file Form 4?
Mary Lake Ph D Polan has filed Form 4 at QDEL (QuidelOrtho Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.